sodium borate, anamirta cocculus seed, gelsemium sempervirens root, wood creosote, toxicodendron pubescens leaf, and tobacco leaf 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1 Tablet, 32-count — NDC 59672-1716-02 package photo

sodium borate, anamirta cocculus seed, gelsemium sempervirens root, wood creosote, toxicodendron pubescens leaf, and tobacco leaf 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1 Tablet, 32-count

by Miers Laboratories · 1 BLISTER PACK in 1 CARTON (59672-1716-2) / 32 TABLET in 1 BLISTER PACK
NDC 59672-1716-02
🏷️ FDA NDC (as labeled) 59672-1716-2 billing pads the package segment with a zero
This package
Contains32-count Pack sizes2 compare ↓
Also comes in: 768 tablets 59672-1716-01
On market Non-controlled
🗂️ Data synced Sep 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 59672-1716-2
Product NDC 59672-1716
11-digit billing NDC 59672171602
SPL Set ID f49b0bd9-00fd-4703-a1ca-f5f14e7ebb5d
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-12-06
Dosage form TABLET
Substance SODIUM BORATE; ANAMIRTA COCCULUS SEED; GELSEMIUM SEMPERVIRENS ROOT; WOOD CREOSOTE; TOXICODENDRON PUBESCENS LEAF; TOBACCO LEAF
Why two NDCs? The FDA registers this code as 59672-1716-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 59672-1716-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerMiers Laboratories
Labeler code59672
First marketedDec 2019
Product typeDrug For Further Processing
Portfolio9 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Trip Ease is an unapproved homeopathic oral tablet containing six plant and mineral ingredients, including sodium borate, various plant extracts (Anamirta cocculus seed, Gelsemium sempervirens root, Toxicodendron pubescens leaf, and tobacco leaf), and wood creosote. In homeopathic tradition, these ingredients are used to address symptoms associated with motion sickness and travel discomfort. Homeopathic products are marketed based on traditional use practices and are not evaluated by the FDA for safety or effectiveness.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color White
ShapeRound
ImprintML
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • 242 mg UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.

3 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesDextrose, and separating agents magnesium stearate and silicon dioxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 768 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
sodium borate, anamirta cocculus seed, gelsemium sempervirens root, wood creosote, toxicodendron pubescens leaf, and tobacco leaf 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]this 59672-1716-02 Miers 32 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2019
On the market since
Dec 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
59672-1716-02 You're viewing this 1 BLISTER PACK in 1 CARTON (59672-1716-2) / 32 TABLET in 1 BLISTER PACK 2023-08-05 Active
59672-1716-01 48 BLISTER PACK in 1 BOX (59672-1716-1) / 16 TABLET in 1 BLISTER PACK — Active

Pack size FAQ

What quantity is in NDC 59672-1716-02?
NDC 59672-1716-02 is a 32-count package — 1 blister pack in 1 carton / 32 tablet in 1 blister pack.
What is the difference between NDC 59672-1716-02 and NDC 59672-1716-01?
Both are sodium borate, anamirta cocculus seed, gelsemium sempervirens root, wood creosote, toxicodendron pubescens leaf, and tobacco leaf 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1 Tablet — the drug itself is identical. NDC 59672-1716-02 is the 32-count package, while NDC 59672-1716-01 is the 768 tablets package.
What NDC number is used to bill for this package of sodium borate, anamirta cocculus seed, gelsemium sempervirens root, wood creosote, toxicodendron pubescens leaf, and tobacco leaf 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1 Tablet?
Bill NDC 59672-1716-02 — the 11-digit billing format is 59672171602. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Miers Laboratories supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 59672-1716-2, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 59672-1716-02, written without dashes as 59672171602. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 59672-1716-02, the first segment (59672) is the labeler code FDA assigned to Miers Laboratories; the middle segment (1716) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Miers Laboratories. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 768 tablets (59672-1716-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Miers Laboratories is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 10 words ▾

Uses For the relief of motion sickness associated with traveling

⏱️ Dosage and Administration 39 words ▾

Directions Age Dose Adults and Children 2 years and over Chew one tablet at start of trip, and one tablet every hour while problem persists. Best taken 1 hour before and after meals. Under 2 years Ask a doctor.

⚠️ Warnings 55 words ▾

Warnings Do not use if the blister pack is broken. Ask a doctor before use in children under 2 years of age Stop use and ask a doctor if symptoms persist for more than 3 days or worsen. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children.

📦 Storage and Handling 11 words ▾

Other Information store under 85°F (30°C) No drug interactions Non drowsy

🧪 Active Ingredient 60 words ▾

Active Ingredients Purpose The letters HPUS indicate that these ingredients are officially included in the Homeopathic Pharmacopeia of the United States. Borax 30C HPUS To reduce stomach upsets Cocculus 30C HPUS To reduce nausea Gelsemium 30C HPUS To reduce dizziness Kreosotum 30C HPUS To reduce stomach pains Rhus Toxicodendron 30C HPUS To reduce vertigo Tabacum 30C HPUS To reduce giddiness

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients Dextrose, and separating agents magnesium stearate and silicon dioxide.

🎯 Purpose 60 words ▾

Active Ingredients Purpose The letters HPUS indicate that these ingredients are officially included in the Homeopathic Pharmacopeia of the United States. Borax 30C HPUS To reduce stomach upsets Cocculus 30C HPUS To reduce nausea Gelsemium 30C HPUS To reduce dizziness Kreosotum 30C HPUS To reduce stomach pains Rhus Toxicodendron 30C HPUS To reduce vertigo Tabacum 30C HPUS To reduce giddiness

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.